BackStrongbridge Biopharma plc Overview

Strongbridge Biopharma plc Cost of Revenue

Cost of Revenue analysis for SBBP.

Quarterly Cost of Revenue

$467000.00
↑ 18.83% YoY

As of Jun 30, 2021

Annual Cost of Revenue (TTM)

$1.73M
↓ 48.4% YoY

Trailing 12 months ending Jun 30, 2021

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin